RIA Advisory Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,724
Closed -$260K 152
2025
Q4
$260K Sell
2,724
-237
-8% -$23.2K 0.06% 120
2025
Q3
$289K Buy
2,961
+10
+0.3% +$1.04K 0.07% 115
2025
Q2
$317K Sell
2,951
-209
-7% -$21.1K 0.09% 94
2025
Q1
$319K Hold
3,160
0.1% 100
2024
Q4
$282K Hold
3,160
0.1% 111
2024
Q3
$265K Buy
+3,160
New +$249K 0.09% 111
2024
Q1
$216K Buy
+3,160
New +$203K 0.09% 128

Other funds holding BSX

RIA Advisory Group's BSX Position: Q1 2026 in Review

RIA Advisory Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,724 shares — an estimated $260K sold.

RIA Advisory Group first reported a position in BSX in Q1 2024 and held it in 7 quarters. The position peaked at $319K in Q1 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • RIA Advisory Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • RIA Advisory Group sold 2,724 Boston Scientific shares in Q1 2026, an estimated $260K.
  • RIA Advisory Group first reported a position in Boston Scientific in Q1 2024 and held it in 7 quarters.
  • RIA Advisory Group's Boston Scientific position peaked at $319K in Q1 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on RIA Advisory Group's 13F filing for Q1 2026, filed 24 Apr 2026.